Tuesday, January 11, 2022

< + > Medicare Seeks To Limit Coverage For Controversial Alzheimer’s Drug Aduhelm

Doctors demanded the FDA revoke its approval for the Alzheimer’s drug Aduhelm, which can cause side effects like brain bleeding.

No comments:

Post a Comment

< + > From Fragmented Data to Actionable Intelligence

Modern tools, including AI, offer healthcare institutions new windows onto their data with the potential for real business changes. In our r...